Led by Dr. Mao Mao and a multidisciplinary team from leading Chinese hospitals, the multicenter retrospective study enrolled 1,814 participants, including 1,095 lung cancer patients. Blood samples ...
Advances in molecular biology have led to new insights regarding lung cancer biology. Blood, sputum bronchoalveolar lavage, bronchoscopic brushing or biopsies, and exhaled breath are sources for the ...
A New York City woman is using her lung cancer survival story to push for early detection, especially among nonsmokers and those in underserved communities. Colette Smith of the Bronx wrote a message ...
The equipment looks futuristic. The demand is widespread. Inside the Thoracic Oncology Mobile Experience Truck parked outside Portsmouth Regional Hospital on Sept. 25, clinicians, research associates ...
A groundbreaking new urine test could soon help spot the early warning signs of lung cancer long before symptoms appear. Scientists at the University of Cambridge, led by Professor Ljiljana Fruk and ...
November marks Lung Cancer Month, a time dedicated to increasing awareness of lung cancer, the leading cause of cancer-related deaths in the United States. According to the American Cancer Society, ...
WALTHAM, Mass., Nov. 20, 2025 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in blood-based detection of early-stage cancer, today announced data from a groundbreaking study leveraging samples ...
Research led by Professors Jianxing He and Wenhua Liang from the First Affiliated Hospital of Guangzhou Medical University and the National Clinical Research Center for Respiratory Disease, focusing ...
SEVEN NEWS. LUNG CANCER REMAINS THE LEADING CAUSE OF CANCER RELATED DEATH IN THE UNITED STATES. AS MEDICAL EXPERT DOCTOR RAMO EXPLAINS, RECENT GUIDELINE CHANGES COULD HELP SAVE THOUSANDS OF LIVES.
O'FALLON, Ill. — Lung cancer is the leading cause of cancer-related deaths among both women and men, yet fewer than 1 in 10 at-risk individuals get screened. This Lung Cancer Awareness Month, health ...
Lung cancer symptoms are often non-specific, leading to late detection and misattribution to less severe conditions. The GO2 for Lung Cancer provides resources, policy advocacy, and access to clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results